Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Taysha Gene Therapies Inc (TSHA)

Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Taysha Gene Therapies Inc 3000 Pegasus Park Dr. Ste 1430 DALLAS TX 75247 USA

www.tayshagtx.com Employees: 52 P: 214-612-0000

Description:

Taysha Gene Therapies Inc. is a patient-centric gene therapy company. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company's product pipeline includes TSHA-101, TSHA-118, TSHA-102, TSHA-103 and TSHA-104 which are in clinical stage. Taysha Gene Therapies Inc. is based in Dallas, Texas.

Key Statistics

Overview:

Market Capitalization, $K 379,145
Enterprise Value, $K 275,265
Shares Outstanding, K 204,943
Annual Sales, $ 15,450 K
Annual Net Income, $ -111,570 K
Last Quarter Sales, $ 1,790 K
Last Quarter Net Income, $ -25,520 K
EBIT, $ -82,490 K
EBITDA, $ -81,120 K
60-Month Beta 0.79
% of Insider Shareholders 2.70%
% of Institutional Shareholders 77.70%
Float, K 199,410
% Float 97.30%
Short Volume Ratio 0.65

Growth:

1-Year Return 30.28%
3-Year Return -85.49%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 11/13/24
Next Earnings Date N/A
Earnings Per Share ttm 0.07
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 30.77%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TSHA Ratios

Ratio
Price/Earnings ttm 26.43
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -106.36%
Return-on-Assets % -49.16%
Profit Margin % -722.14%
Debt/Equity 0.48
Price/Sales 24.54
Price/Cash Flow N/A
Price/Book 4.27
Book Value/Share 0.43
Interest Coverage -21.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar